As one of the biggest colleges at the University of Utah, College of Health faculty, staff, and students continually celebrate new accomplishments, including these highlights from 2024.
Explore various ARPA-H funding opportunities that include research in imaging data exchange, advancing clinical trial readiness, and the emerging health innovators initiative.
Funding opportunities are available across a variety of fields and specialties, ranging from digital health technology, to tobacco, alcohol, and cannabis policy, to environmental health and more.
Take a look at several foundation funding opportunities provided by the advancement team. These opportunities come from foundations such as the AFAR, Glenn Foundation and the Whitehall Foundation.
From new educational programs to new leadership and new traditions, the University of Utah College of Pharmacy experienced a year defined by innovation and change.
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
At Learn, Serve, Lead 2024, AAMC leaders remind annual meeting attendees that despite challenges, they are making a difference in the lives of patients and colleagues.
Prenatal exposure to ozone pollution could be harming the cognitive development of unborn children, according to new interdisciplinary research from the University of Utah. The peer-reviewed study found a strong...
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
Academic research—and funding that supports it—has vast societal impact. Research improves scientific understanding, health care delivery, and quality of life while growing our economy and training future scientists.
